Md. offers COVID-19 antibody treatment to high-risk patients with mild symptoms

There’s a relatively new treatment for certain COVID-19 patients that Maryland’s Health Department is making available for residents to consider. Monoclonal antibody therapy can help prevent mild COVID-19 symptoms from developing into issues that are more serious. The Food and Drug Administration approved its use in November for people 65-years-old and up or younger people with chronic medical conditions such as kidney disease, diabetes, heart disease or chronic lung disease.